What is Doctolib?
Founded in 2013 and headquartered in Paris, France, Doctolib is a prominent online health service platform. It facilitates the connection between doctors and patients, streamlining access to healthcare services. The company's operations are critical in modernizing healthcare delivery through digital solutions, enhancing efficiency for medical professionals and improving patient convenience. Doctolib's expansion into various European markets highlights its significant impact on the healthtech landscape.
How much funding has Doctolib raised?
Doctolib has raised a total of $813.9M across 7 funding rounds:
Angel/Seed
$1.2M
Series A
$4.9M
Series B
$20M
Series C
$28M
Private Equity
$42M
Unspecified
$170M
Other Financing Round
$547.8M
Angel/Seed (2014): $1.2M, investors not publicly disclosed
Series A (2014): $4.9M, investors not publicly disclosed
Series B (2015): $20M supported by Accel Partners
Series C (2017): $28M featuring Bpifrance and Accel
Private Equity (2017): $42M backed by Bpifrance and Eurazeo
Unspecified (2019): $170M with participation from General Atlantic, Accel, Kernel, Eurazeo, and Bpifrance
Other Financing Round (2022): $547.8M led by Eurazeo, Bpifrance, and General Atlantic
Key Investors in Doctolib
Eurazeo
Eurazeo is a leading global investment company based in Paris, founded in 1969. It specializes in private equity, venture capital, real estate, and private debt, supporting companies of all sizes in their development with deep sector expertise and a global market gateway.
Bpifrance
Bpifrance, established in 2012, finances companies across all development stages with credit, guarantees, and equity. It supports innovation and international projects, ensuring export activities and offering consulting and acceleration programs for businesses.
General Atlantic
General Atlantic is a global growth-equity firm providing capital and strategic support to high-growth companies in sectors like consumer, financial services, healthcare, life sciences, and technology. They partner with founders to accelerate growth and international expansion.
What's next for Doctolib?
With substantial backing, Doctolib is poised for continued expansion and technological advancement. The enterprise-level funding suggests a focus on scaling operations, potentially entering new geographic markets, and further developing its platform's capabilities. Strategic investments of this magnitude typically signal an intent to solidify market leadership, enhance service offerings, and explore new avenues for growth within the rapidly evolving digital health ecosystem. Future developments may include deeper integration with healthcare providers and expanded patient-facing features.
See full Doctolib company page
